Proteins C5 anaphylatoxin and gliomedin that serve as diagnostic biomarkers to identify Neuro-PASC subjects with 88 % sensitivity and 88–91 % specificity versus healthy controls and 80 % versus convalescent controls. The gene discussed is GLDN; the disease is long COVID-19.